A contribution to a history of the placebo effect

A crystallized tear From the eye of a deer— Bitten by a snake— Made people well. So who can foretell What cures placebos make?.

[1]  J. Frank,et al.  Psychotherapy and the placebo effect. , 2011, Psychological bulletin.

[2]  H. Beecher.  Evidence for increased effectiveness of placebos with increased stress. , 1956, The American journal of physiology.

[3]  S. Wolf.  Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos. , 1950, The Journal of clinical investigation.

[4]  D. Trouton.  Placebos and their psychological effects. , 1957, The Journal of mental science.

[5]  J. Elkes,et al.  Effect of Chlorpromazine on the Behaviour of Chronically Overactive Psychotic Patients , 1954, British medical journal.

[6]  W. Lennox.  The centenary of bromides. , 1957, The New England journal of medicine.

[7]  T. Findley.  The placebo and the physician. , 1953, The Medical clinics of North America.

[8]  M. Hollender.  The psychology of medical practice , 1958 .

[9]  L. Lasagna,et al.  The optimal dose of morphine. , 1954, Journal of the American Medical Association.

[10]  R. Platt.  Two essays on the practice of medicine. , 1947, Lancet.

[11]  R. Tibbetts,et al.  The placebo response. , 1956, The Journal of mental science.

[12]  F. Mosteller,et al.  A study of the placebo response. , 1954, The American journal of medicine.

[13]  H. Beecher.  The subjective response and reaction to sensation; the reaction phase as the effective site for drug action. , 1956, The American journal of medicine.

[14]  H. Hollingworth.  The Influence of caffein on mental and motor efficiency , 2009 .

[15]  S. Wolf,et al.  The action of banthine on the stomach and duodenum of man with observations on the effects of placebos. , 1952, Gastroenterology.

[16]  A. Dawson,et al.  The Use and Abuse of Cathartics. , 1932, California and western medicine.

[17]  W. Houston.  THE DOCTOR HIMSELF AS A THERAPEUTIC AGENT , 1938 .

[18]  M. Fink,et al.  Comparative study of chlorpromazine and insulin coma in therapy of psychosis. , 1958, Journal of the American Medical Association.

[19]  A. Carter.  The placebo; its use and abuse. , 1953, The Lancet.

[20]  A. Leslie.  Ethics and practice of placebo therapy. , 1954, The American journal of medicine.

[21]  H. Beecher,et al.  The powerful placebo. , 1955, Journal of the American Medical Association.

[22]  H. Bourne.  Insulin coma in decline. , 1958, The American journal of psychiatry.

[23]  W. Gantt,et al.  Some implications of conditional reflex studies for placebo research. , 1957, The American journal of psychiatry.

[24]  R. Handfield-Jones.  A bottle of medicine from the doctor. , 1953, Lancet.

[25]  M BALINT,et al.  The doctor, his patient, and the illness. , 1957, Lancet.

[26]  S. Block.  Hippocrates on psychotherapy by the general practitioner. , 1957, The New England journal of medicine.

[27]  A. Kurland.  The drug placebo–its psychodynamic and conditional reflex action , 2007 .

[28]  E. Levitt.  The results of psychotherapy with children: an evaluation. , 1957, Journal of consulting psychology.

[29]  H. Rashkis,et al.  Psychopharmacotherapeutic research; a triadistic approach. , 1957, A.M.A. archives of neurology and psychiatry.

[30]  H. Rashkis,et al.  Drug and milieu effects with chronic schizophrenics. , 1957, A.M.A. archives of neurology and psychiatry.

[31]  F. Mosteller,et al.  Measurement of pathological pain in distinction to experimental pain. , 1950, Journal of applied physiology.

[32]  S. Imber,et al.  Why patients leave psychotherapy. , 1957, A.M.A. archives of neurology and psychiatry.

[33]  S. Karagulla.  Evaluation of electric convulsion therapy as compared with conservative methods of treatment in depressive states. , 1950, The Journal of mental science.

[34]  D. Dunlop.  Survey of 17,301 Prescriptions on Form E.C.10 , 1952 .

[35]  Dlin Bm,et al.  The dynamics of placebo therapy: a clinical study. , 1956 .

[36]  Glaser Em,et al.  Experimental errors in clinical trials. , 1954 .

[37]  F. Mosteller,et al.  The effectiveness of oral analgesics (morphine, codeine, acetylsalicylic acid) and the problem of placebo "reactors" and "non-reactors". , 1953, The Journal of pharmacology and experimental therapeutics.

[38]  R. Cabot.  The Physician's Responsibility for the Nostrum Evil. , 1906, California state journal of medicine.

[39]  M. Sabshin,et al.  Pharmacotherapeutic evaluation and the psychiatric setting. , 1956, A.M.A. archives of neurology and psychiatry.

[40]  H. Beecher,et al.  Experimental pharmacology and measurement of the subjective response. , 1952 .

[41]  P. Feldman.  The personal element in psychiatric research. , 1956, The American journal of psychiatry.

[42]  J. Frank,et al.  Improvement and amount of therapeutic contact: an alternative to the use of no-treatment controls in psychotherapy. , 1957, Journal of consulting psychology.

[43]  B. Weiss,et al.  A critical review of the efficacy of meprobamate (miltown, equanil) in the treatment of anxiety. , 1958, Journal of chronic diseases.

[44]  Smith Ja,et al.  Evaluation of treatment procedures in psychiatry. , 1957 .

[45]  N. Bigelow,et al.  On a methodology for the clinical evaluation of phrenopraxic drugs , 2005, The Psychiatric Quarterly.

[46]  R. Boardman,et al.  Insulin and chlorpromazine in schizophrenia; a comparative study in previously untreated cases. , 1956, Lancet.

[47]  H. Beecher,et al.  The measurement of pain; prototype for the quantitative study of subjective responses. , 1957, Pharmacological reviews.

[48]  J. O'Brien.  Is Liver a “Tonic”? , 1954 .

[49]  Hofling Ck.  The place of placebos in medical practice. , 1955 .

[50]  M. Horwitt.  Fact and artifact in the biology of schizophrenia. , 1956, Science.

[51]  H. Abramson,et al.  Lysergic Acid Diethylamide (Lsd-25): Xv. the Effects Produced By Substitution of a Tap Water Placebo , 1955 .

[52]  H. Bourne.  The insulin myth. , 1953, Lancet.

[53]  D. Hastings.  Follow-up results in psychiatric illness. , 1958, The American journal of psychiatry.

[54]  L. Lasagna,et al.  Drug-induced mood changes in man. II. Personality and reactions to drugs. , 1955, Journal of the American Medical Association.

[55]  H. Koteen.  Use of a "double-blind" study investigating the clinical merits of a new tranquilizing agent. , 1957, Annals of Internal Medicine.

[56]  D. Levinson,et al.  Placebo effect, social milieu, and the evaluation of psychiatric therapies. , 1959, Journal of chronic diseases.

[57]  A. Harris,et al.  Insulin treatment of schizophrenia; a controlled study. , 1957, Lancet.

[58]  Debenham Gp.  USE AND ABUSE OF DRUGS. , 1965 .

[59]  S. Wolf,et al.  Effects of placebo administration and occurrence of toxic reactions. , 1954, Journal of the American Medical Association.

[60]  M. Reiser,et al.  Comparison of Blood Pressure Response to Veriloid and to the Doctor , 1954, Psychosomatic medicine.

[61]  D. Ayman.  AN EVALUATION OF THERAPEUTIC RESULTS IN ESSENTIAL HYPERTENSION: I. THE INTERPRETATION OF SYMPTOMATIC RELIEF , 1930 .

[62]  S. Imber,et al.  Reduction of symptoms by pharmacologically inert substances and by short-term psychotherapy. , 1958, A.M.A. archives of neurology and psychiatry.

[63]  E. Huskisson.  Measurement of pain. , 1974, Lancet.

[64]  C. R. Doering,et al.  Chance distribution and placebo reactor. , 1957, The Journal of laboratory and clinical medicine.

[65]  I. Cohen.  An Interview with Einstein , 1955 .

[66]  J. Zubin,et al.  A biometric evaluation of the somatotherapies in schizophrenia. , 1957, Psychological bulletin.